PITTSBURGH - The generic drug giant Mylan Inc. has sued the Pittsburgh Post-Gazette over stories based on internal documents that prompted a review by the Food and Drug Administration.
The FDA this month concluded Mylan did nothing wrong. The newspaper reported in July that Mylan employees in Morgantown, W.Va., regularly overrode computer-generated warnings about potential problems with making medications.
Mylan said its internal investigation found that quality was not affected.
The suit alleges misappropriation of trade secrets.
Publisher and editor in chief John Robinson Block said the paper had not seen the complaint, “But the Post-Gazette stands fully behind its reporting and its news gathering.’’
The articles were based on improperly obtained and misconstrued confidential and proprietary documents, according to the suit. The suit asks for the documents back, along with an unspecified amount of money.
The “sensational misuse’’ of the documents harmed Mylan and its shareholders, the suit said.